DYLAN WILLIAMS: Open Payments
NPI 1285314690 · THIBODAUX, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$810 in 23 payments from 9 companies in 2025. Trend: 2023 $243 · 2024 $843 · 2025 $810
Food & beverage: $810
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 3 | $191 |
| Novo Nordisk Inc | 5 | $181 |
| Kestra Medical Technology Services, Inc. | 2 | $181 |
| Novartis Pharmaceuticals Corporation | 7 | $139 |
| Amgen Inc. | 2 | $33 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $32 |
| PFIZER INC. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: Assure WCD, Wegovy, LEQVIO, REPATHA, LifeVest, ELIQUIS, Ozempic, VERQUVO.
Industry payments across LA — which companies pay providers there.
